本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nautilus Biotechnolgy, Inc.

0.7579
-0.0031-0.41%
盘后0.7428-0.0151-1.99%17:37 EDT
成交量:7.94万
成交额:6.08万
市值:9,560.79万
市盈率:-1.39
高:0.7856
开:0.7680
低:0.7500
收:0.7610
数据加载中...
2025/06/23

重要事件披露

Form 8-K - Current report
2025/05/02

重要事件披露

Form 8-K - Current report
2025/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/31

重要事件披露

Form 8-K - Current report
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]